FDA Inspection 1013036 — Sandoz Incorporated
The FDA completed an inspection of Sandoz Incorporated on March 29, 2017 in East Hanover, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- East Hanover, NJ (United States)